Literature DB >> 6356226

The present status of chelating agents in medicine.

P M May, R A Bulman.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6356226     DOI： 10.1016/s0079-6468(08)70220-0

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  11 in total

1.  Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  Methods Mol Biol       Date:  2010

2.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

3.  Biospeciation, by potentiometry and computer simulation, of Sm-EDTMP, a bone tumor palliative agent.

Authors:  G Charmaine de Witt; P M May; J Webb; G Hefter
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

Review 4.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

5.  A new approach to evaluate toxic metal transport in a catchment.

Authors:  Emilli Frachini; Leonel Vinicius Constantino; Taufik Abrao; Maria Josefa Santos
Journal:  Environ Monit Assess       Date:  2020-03-13       Impact factor: 2.513

6.  Metal ion-tetracycline interactions in biological fluids. Part 5. Formation of zinc complexes with tetracycline and some of its derivatives and assessment of their biological significance.

Authors:  M Brion; L Lambs; G Berthon
Journal:  Agents Actions       Date:  1985-12

7.  Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II).

Authors:  D R Richardson; G T Hefter; P M May; J Webb; E Baker
Journal:  Biol Met       Date:  1989

8.  Metal binding by pharmaceuticals. Part 5. Interaction of Cd(II), Ni(II) and Pb(II) with the intracellular hydrolysis products of the anti-tumour agent ICRF 159 and its inactive homologue ICRF 192.

Authors:  P M May; M J Willes; D R Williams; A M Creighton
Journal:  Agents Actions       Date:  1984-10

9.  Interaction of 5'-Guanosine Monophosphate with Organotin(IV) Moieties: Synthesis, Structural Characterization, and Anti-Inflammatory Activity.

Authors:  Mala Nath; Hitendra Singh; George Eng; Xueqing Song
Journal:  ISRN Org Chem       Date:  2012-09-30

Review 10.  Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications.

Authors:  Jun-Lin Liu; Yong-Gang Fan; Zheng-Sheng Yang; Zhan-You Wang; Chuang Guo
Journal:  Front Neurosci       Date:  2018-09-10       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.